Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for HEPATITIS B SURFACE ANTIGEN

Ingredient

HEPATITIS B SURFACE ANTIGEN

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
ENGERIX-B	10MCG	SUSPENSION	Resolved	2022-10-07	2022-10-13	171261
ENGERIX-B	10MCG	SUSPENSION	Resolved	2022-03-15	2022-04-13	156738
ENGERIX-B	10MCG	SUSPENSION	Resolved	2021-06-28	2021-07-20	141615
ENGERIX-B	10MCG	SUSPENSION	Resolved	2018-05-17	2018-11-30	49681
RECOMBIVAX HB	10MCG	SUSPENSION SOLUTION	Actual shortage	2025-11-03	2025-11-10	270854
RECOMBIVAX HB	10MCG	SUSPENSION SOLUTION	Resolved	2024-01-10	2024-02-14	215470
RECOMBIVAX HB	10MCG	SUSPENSION SOLUTION	Resolved	2022-11-24	2023-05-12	175542
RECOMBIVAX HB	40MCG	SOLUTION	Resolved	2017-08-11	2017-10-07	18922
RECOMBIVAX HB	40MCG	SOLUTION	Resolved	2018-06-13	2021-03-16	52350
RECOMBIVAX HB	10MCG	SOLUTION	Resolved	2018-03-19	2020-09-11	43284

Showing 11 to 20 of 34

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
ENGERIX-B	20MCG	SUSPENSION	Discontinued	2019-12-10	2020-05-27	100904
ENGERIX-B	10MCG	SUSPENSION	Discontinued	2019-12-10	2020-04-30	100907

1

Showing 1 to 2 of 2